Literature DB >> 20472488

GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population.

C Kiyohara1, Y Miyake, M Koyanagi, T Fujimoto, S Shirasawa, K Tanaka, W Fukushima, S Sasaki, Y Tsuboi, T Yamada, T Oeda, T Miki, N Kawamura, N Sakae, H Fukuyama, Y Hirota, M Nagai.   

Abstract

Patients with idiopathic Parkinson's disease (PD) appear to have reduced capacity for detoxification of certain environmental compounds. The glutathione S-transferases (GSTs) are candidate genes for PD because they are involved in the metabolism of pesticides and cigarette smoke. We investigated the relationship of the seven GST polymorphisms (GSTM1 deletion, GSTT1 deletion, GSTP1 rs1695, GSTO1 rs4925, GSTO1 rs11191972, GSTO2 rs156697 and GSTO2 rs2297235) and PD risk with special reference to the interaction with pesticide use or cigarette smoking among 238 patients with PD cases and 370 controls in a Japanese population. None of the GST polymorphisms were associated with PD. GSTO1 rs4925 and GSTO2 rs2297235 were found to be in strong linkage disequilibrium (D' = 0.98). Cigarette smoking was significantly associated with decreased risk of PD. However, no interaction of smoking with any of the GST polymorphisms was observed. Self-reported pesticide use was not associated with increased risk of PD. There was no evidence of interaction between self-reported pesticide use and either GST polymorphism. Our results suggest that the tested GST polymorphisms did not play an important role in PD susceptibility in our Japanese population. Our study does not give evidence of interaction between the GST polymorphisms and smoking may although this study provided sufficient statistical power to detect modest interaction. As for interaction between GSTP polymorphisms and pesticide use, the power of this study to detect an interactive effect was low due to a small number of pesticide users. Future studies involving larger control and case populations and better pesticide exposure histories will undoubtedly lead to a more thorough understanding of the role of the GST polymorphisms in PD development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472488     DOI: 10.1016/j.parkreldis.2010.04.009

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  14 in total

1.  In search of the causes of Parkinson's disease, seasons 1 to 4.

Authors:  Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-05-31       Impact factor: 8.082

2.  Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Masaaki Okubo; Hiromi Yamashita; Daisuke Yoshioka; Joh Yonemura; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Virchows Arch       Date:  2011-01-14       Impact factor: 4.064

3.  Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.

Authors:  Gun Wu; Bin Jiang; Xiaoqin Liu; Yi Shen; Shujuan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Glutathione S-transferase T1 and M1 null genotypes and Parkinson's disease risk: evidence from an updated meta-analysis.

Authors:  Hongzhou Liu; Jie Peng; Jiajia Gao; Fang Zheng; Chaorong Tie
Journal:  Neurol Sci       Date:  2015-04-14       Impact factor: 3.307

5.  Genetic modification of the association of paraquat and Parkinson's disease.

Authors:  Samuel M Goldman; Freya Kamel; G Webster Ross; Grace S Bhudhikanok; Jane A Hoppin; Monica Korell; Connie Marras; Cheryl Meng; David M Umbach; Meike Kasten; Anabel R Chade; Kathleen Comyns; Marie B Richards; Dale P Sandler; Aaron Blair; J William Langston; Caroline M Tanner
Journal:  Mov Disord       Date:  2012-10-08       Impact factor: 10.338

6.  Null genotype of GSTT1 contributes to increased Parkinson's disease risk in Caucasians: evidence from a meta-analysis.

Authors:  Dan Wang; Jun-Xia Zhai; Li-Mei Zhang; Dian-Wu Liu
Journal:  Mol Biol Rep       Date:  2014-08-03       Impact factor: 2.316

7.  Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: association with glutathione-S-transferase and DNA repair gene polymorphisms.

Authors:  Tommaso Cornetta; Clarice Patrono; Irene Terrenato; Francesca De Nigris; Anna Rita Bentivoglio; Antonella Testa; Valentina Palma; Tommaso Poggioli; Luca Padua; Renata Cozzi
Journal:  Cell Mol Neurobiol       Date:  2013-04-04       Impact factor: 5.046

Review 8.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

9.  Influence of GSTO2 (N142D) genetic polymorphism on acute renal rejection.

Authors:  Nioosha Nekooie-Marnany; Iraj Saadat; Mohammad-Hossein Karimi; Jamshid Roozbeh; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2013-05-07       Impact factor: 2.316

10.  Association of glutathione S-transferase T1 and M1 gene polymorphisms with ischemic stroke risk in the Chinese Han population.

Authors:  Rui Wang; Yan Wang; Junhong Wang; Kun Yang
Journal:  Neural Regen Res       Date:  2012-06-25       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.